|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu M, Wang JY, Zhang YG, Zhu SC, Lu ZH
and Wan B: Detection of urological and male genital tumors
diagnosed in Beijing Hospital 1995–2004. Zhonghua Yi Xue Za Zhi.
87:2423–2425. 2007.(In Chinese). PubMed/NCBI
|
|
3
|
Xu J, Sun J and Zheng SL: Prostate cancer
risk-associated genetic markers and their potential clinical
utility. Asian J Androl. 15:314–322. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eeles R, Goh C, Castro E, Bancroft E, Guy
M, Al Olama AA, Easton D and Kote-Jarai Z: The genetic epidemiology
of prostate cancer and its clinical implications. Nat Rev Urol.
11:18–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Na R, Liu F, Zhang P, Ye D, Xu C, Shao Q,
Qi J, Wang X, Chen Z, Wang M, et al: Evaluation of reported
prostate cancer risk-associated SNPs from genome-wide association
studies of various racial populations in Chinese men. Prostate.
73:1623–1635. 2013.PubMed/NCBI
|
|
6
|
Aly M, Wiklund F, Xu J, Isaacs WB, Eklund
M, D'Amato M, Adolfsson J and Grönberg H: Polygenic risk score
improves prostate cancer risk prediction: Results from the
Stockholm-1 cohort study. Eur Urol. 60:21–28. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kader AK, Sun J, Reck BH, Newcombe PJ, Kim
ST, Hsu FC, D'Agostino RB Jr, Tao S, Zhang Z, Turner AR, et al:
Potential impact of adding genetic markers to clinical parameters
in predicting prostate biopsy outcomes in men following an initial
negative biopsy: Findings from the REDUCE trial. Eur Urol.
62:953–961. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang H, Liu F, Wang Z, Na R, Zhang L, Wu
Y, Zheng J, Lin X, Jiang D, Sun J, et al: Prediction of prostate
cancer from prostate biopsy in Chinese men using a genetic score
derived from 24 prostate cancer risk-associated SNPs. Prostate.
73:1651–1659. 2013.PubMed/NCBI
|
|
9
|
Ren S, Xu J, Zhou T, Jiang H, Chen H, Liu
F, Na R, Zhang L, Wu Y, Sun J, et al: Plateau effect of prostate
cancer risk-associated SNPs in discriminating prostate biopsy
outcomes. Prostate. 73:1824–1835. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Al Olama AA, Kote-Jarai Z, Berndt SI,
Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z,
Saunders E, et al: A meta-analysis of 87,040 individuals identifies
23 new susceptibility loci for prostate cancer. Nature Genetics.
46:1103–1109. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu F, Hsing AW, Wang X, Shao Q, Qi J, Ye
Y, Wang Z, Chen H, Gao X, Wang G, et al: Systematic confirmation
study of reported prostate cancer risk-associated single nucleotide
polymorphisms in Chinese men. Cancer Sci. 102:1916–1920. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang M, Liu F, Hsing AW, Wang X, Shao Q,
Qi J, Ye Y, Wang Z, Chen H, Gao X, et al: Replication and
cumulative effects of GWAS-identified genetic variations for
prostate cancer in Asians: A case-control study in the ChinaPCa
consortium. Carcinogenesis. 33:356–360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu J, Mo Z, Ye D, Wang M, Liu F, Jin G, Xu
C, Wang X, Shao Q, Chen Z, et al: Genome-wide association study in
Chinese men identifies two new prostate cancer risk loci at 9q31.2
and 19q13.4. Nat Genet. 44:1231–1235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marchini J, Howie B, Myers S, McVean G and
Donnelly P: A new multipoint method for genome-wide association
studies by imputation of genotypes. Nat Genet. 39:906–913. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu Y, Zhang N, Li K, Chen H, Lin X, Yu Y,
Gou Y, Hou J, Jiang D, Na R, et al: Genetic scores based on
risk-associated single nucleotide polymorphisms (SNPs) can reveal
inherited risk of renal cell carcinoma. Oncotarget. 7:18631–18637.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang M, Takahashi A, Liu F, Ye D, Ding Q,
Qin C, Yin C, Zhang Z, Matsuda K, Kubo M, et al: Large-scale
association analysis in Asians identifies new susceptibility loci
for prostate cancer. Nat Commun. 6:84692015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
1000 Genomes Project Consortium, . Auton
A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini
JL, McCarthy S, McVean GA and Abecasis GR: A global reference for
human genetic variation. Nature. 526:68–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Purcell S, Neale B, Todd-Brown K, Thomas
L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ
and Sham PC: PLINK: A tool set for whole-genome association and
population-based linkage analyses. Am J Hum Genet. 81:559–575.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
DeLong ER, DeLong DM and Clarke-Pearson
DL: Comparing the areas under two or more correlated receiver
operating characteristic curves: A nonparametric approach.
Biometrics. 44:837–845. 1988. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Na R, Ye D, Qi J, Liu F, Lin X, Helfand
BT, Brendler CB, Conran C, Gong J, Wu Y, et al: Race-specific
genetic risk score is more accurate than nonrace-specific genetic
risk score for predicting prostate cancer and high-grade diseases.
Asian J Androl. 18:525–529. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lichtenstein P, Holm NV, Verkasalo PK,
Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A and Hemminki
K: Environmental and heritable factors in the causation of
cancer-analyses of cohorts of twins from Sweden, Denmark, and
Finland. N Engl J Med. 343:78–85. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Michailidou K, Hall P, Gonzalez-Neira A,
Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J,
Bojesen SE, Bolla MK, et al: Large-scale genotyping identifies 41
new loci associated with breast cancer risk. Nat Genet. 45:353–361.
2013. View
Article : Google Scholar : PubMed/NCBI
|
